Target Sectors Potential sales opportunities exist in high-stakes sectors served by QI Path, including healthcare, biopharma, and government. Emphasize AI-driven risk intelligence for clinical trials, drug manufacturing, healthcare delivery, and defense readiness to tailor value propositions to each vertical.

Proactive Risk Position the platform as a proactive risk mitigation solution that reduces waste, rework, and uncertainty in mission-critical programs. Highlight how Adaptive Risk Intelligence can surface and prioritize vulnerabilities before they become failures in complex systems.

Scale via Cloud Leverage the cloud-based QIP System to address cross-functional teams and enterprise-wide risk management needs. Frame ROI around accelerated proactive planning, improved collaboration, and system-wide improvements across multi-site operations.

Evidence of Traction With annual revenue in the tens of millions and a focused team size, pursue mid-market to niche enterprise opportunities that require specialized risk intelligence. Use this to target organizations undergoing digital transformation and regulatory-compliance upgrades.

Strategic Partnerships Explore partnerships and demos with healthcare providers, biopharma manufacturers, and government agencies. Emphasize demonstrated capabilities of ARIS Adaptive Risk Intelligence System to drive readiness, compliance, and safer operations.